Advances have been made in the field of nonalcoholic fatty liver disease in 2019. One paper highlights the role of gut microbiota in hepatocellular carcinoma (HCC) pathogenesis, another presents a noninvasive algorithm for detecting advanced liver fibrosis and another suggests a potential novel approach to treating nonalcoholic steatohepatitis and suppressing HCC development.
|Titolo:||What's new in NAFLD pathogenesis, biomarkers and treatment?|
TARGHER, Giovanni [Writing – Original Draft Preparation]
|Data di pubblicazione:||2020|
|Appare nelle tipologie:||01.01 Articolo in Rivista|